Clinical Trial Update: Taldefgrobep Alfa in Adults With Overweight and Obesity [Phase 2]

View source ↗

Summary

This entry provides an update on a Phase 2 clinical trial of Taldefgrobep alfa in adults with overweight and obesity, with the study currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Taldefgrobep alfa (taldefgrobep alfa)

Snippet

Sponsor: Biohaven Therapeutics Ltd. | Conditions: Obesity, Overweight | Phase 2 | Status: ACTIVE_NOT_RECRUITING